sangui biotech intl inc
(SBH:Hamburg Stock Exchange)
sangui biotech intl inc (SBH) Snapshot
|
Open
€0.14
|
Previous Close
€0.13
|
|
|
Day High
€0.14
|
Day Low
€0.13
|
|
|
52 Week High
07/17/12 - €0.43
|
52 Week Low
04/19/13 - €0.10
|
|
|
Market Cap
--
|
Average Volume 10 Days
79.3K
|
|
|
EPS TTM
--
|
Shares Outstanding
0.0
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
sangui biotech intl inc (SBH) Related Businessweek News
No Related Businessweek News Foundsangui biotech intl inc (SBH) Details
Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, engages in the research, development, manufacture, and sale of pharmaceutical, medical, and cosmetic products primarily in Europe. The company develops nano formulations for the regeneration and moisturization of the skin, and enhanced skin elasticity. It also offers Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray product under the Granulox brand name; and cosmetic products through Internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is based in Witten, Germany.
sangui biotech intl inc (SBH) Top Compensated Officers
sangui biotech intl inc (SBH) Key Developments
Sangui Biotech International Inc. announced earnings results for the third quarter and nine months for the financial year 2013. For the quarter, the company reported revenues from product sales and royalties of above USD 33,000 compared to USD 571 in the same period a year ago. For the nine months period, the company's revenues amounted to more than USD 81,000 compared to USD 2,795 in the same period a year ago. Company used cash in operations of approximately USD 500,000 compared to USD 461,000 in the same period a year ago.
On 05/15/2013, Sangui Biotech International Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
On 11/15/2012, Sangui Biotech International Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
| Recently Viewed | |||
| SBH:GR | €0.14 EUR | +0.009 |  |
| Company | Last | Change | |
| No competitor information is available for SBH. | |||
| View Industry Companies | |||
Industry Analysis
SBH
Industry Average
| Valuation | SBH | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 253.6x |
|
| Price/Book | 14.3x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 259.0x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact SANGUI BIOTECH INTL INC, please visit www.sanguibiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
